PortfoliosLab logoPortfoliosLab logo
ELV vs. AVGO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELV vs. AVGO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elevance Health, Inc. (ELV) and Broadcom Inc. (AVGO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELV achieves a 7.45% return, which is significantly lower than AVGO's 8.59% return. Over the past 10 years, ELV has underperformed AVGO with an annualized return of 12.24%, while AVGO has yielded a comparatively higher 40.36% annualized return.


ELV

1D
-4.48%
1M
-6.27%
6M
-1.38%
YTD
7.45%
1Y
10.49%
3Y*
-3.60%
5Y*
0.35%
10Y*
12.24%

AVGO

1D
-5.03%
1M
-0.44%
6M
9.56%
YTD
8.59%
1Y
34.32%
3Y*
62.16%
5Y*
54.44%
10Y*
40.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELV vs. AVGO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ELV
Elevance Health, Inc.
7.45%-3.14%-20.72%-6.89%11.83%46.12%7.74%16.33%18.11%58.72%
AVGO
Broadcom Inc.
8.59%50.63%110.49%104.18%-13.27%56.48%44.88%29.05%2.18%48.19%

Correlation

The correlation between ELV and AVGO is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.09

Correlation (3Y)
Calculated over the trailing 3-year period

-0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Aug 6, 2009

0.22

The correlation between ELV and AVGO shifts across timeframes, from -0.09 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ELV:

$80.97B

AVGO:

$1.78T

EPS

ELV:

$22.41

AVGO:

$6.01

PE Ratio

ELV:

16.64

AVGO:

62.31

PS Ratio

ELV:

0.41

AVGO:

24.21

PB Ratio

ELV:

1.81

AVGO:

20.82

Total Revenue (TTM)

ELV:

$201.11B

AVGO:

$75.47B

Gross Profit (TTM)

ELV:

$78.34B

AVGO:

$50.53B

EBITDA (TTM)

ELV:

$8.01B

AVGO:

$42.03B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELV vs. AVGO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELV
ELV Risk / Return Rank: 5353
Overall Rank
ELV Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
ELV Sortino Ratio Rank: 4848
Sortino Ratio Rank
ELV Omega Ratio Rank: 5151
Omega Ratio Rank
ELV Calmar Ratio Rank: 5555
Calmar Ratio Rank
ELV Martin Ratio Rank: 5757
Martin Ratio Rank

AVGO
AVGO Risk / Return Rank: 6767
Overall Rank
AVGO Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
AVGO Sortino Ratio Rank: 6464
Sortino Ratio Rank
AVGO Omega Ratio Rank: 6464
Omega Ratio Rank
AVGO Calmar Ratio Rank: 6969
Calmar Ratio Rank
AVGO Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELV vs. AVGO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elevance Health, Inc. (ELV) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ELVAVGODifference
Sharpe ratioReturn per unit of total volatility

-0.46

Sortino ratioReturn per unit of downside risk

-0.69

Omega ratioGain probability vs. loss probability

1.09

1.16

-0.07

Calmar ratioReturn relative to maximum drawdown

0.40

1.20

-0.81

Martin ratioReturn relative to average drawdown

1.03

2.51

-1.48

ELV vs. AVGO - Sharpe Ratio Comparison

The current ELV Sharpe Ratio is 0.27, which is lower than the AVGO Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of ELV and AVGO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ELV vs. AVGO - Drawdown Comparison

The maximum ELV drawdown since its inception was -67.19%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for ELV and AVGO.


Loading charts...

Drawdown Indicators


ELVAVGODifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-48.30%

-18.89%

Max Drawdown (1Y)

Largest decline over 1 year

-26.49%

-28.67%

+2.18%

Max Drawdown (3Y)

Largest decline over 3 years

-50.38%

-41.15%

-9.23%

Max Drawdown (5Y)

Largest decline over 5 years

-50.38%

-41.15%

-9.23%

Max Drawdown (10Y)

Largest decline over 10 years

-50.38%

-48.30%

-2.08%

Current Drawdown

Current decline from peak

-31.23%

-22.12%

-9.11%

Average Drawdown

Average peak-to-trough decline

-15.33%

-8.05%

-7.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.60%

13.70%

-2.10%

Volatility

ELV vs. AVGO - Volatility Comparison

Elevance Health, Inc. (ELV) and Broadcom Inc. (AVGO) have volatilities of 14.30% and 14.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELVAVGODifference

Volatility (1M)

Calculated over the trailing 1-month period

14.30%

14.97%

-0.67%

Volatility (6M)

Calculated over the trailing 6-month period

29.89%

34.62%

-4.73%

Volatility (1Y)

Calculated over the trailing 1-year period

39.24%

47.22%

-7.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.62%

43.86%

-14.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.12%

39.67%

-8.55%

Dividends

ELV vs. AVGO - Dividend Comparison

ELV's dividend yield for the trailing twelve months is around 1.84%, more than AVGO's 0.68% yield.


PositionTTM20252024202320222021202020192018201720162015
AVGO
Broadcom Inc.
0.68%0.70%0.94%1.71%3.02%2.24%3.05%3.54%3.11%1.87%1.43%1.13%
ELV
Elevance Health, Inc.
1.84%1.95%1.77%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%

Financials

ELV vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between Elevance Health, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B20.00B30.00B40.00B50.00B20222023202420252026
50.47B
22.19B
(ELV) Total Revenue
(AVGO) Total Revenue
Values in USD except per share items

ELV vs. AVGO - Profitability Comparison

The chart below illustrates the profitability comparison between Elevance Health, Inc. and Broadcom Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%20222023202420252026
89.1%
67.2%
Portfolio components
ELV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported a gross profit of 44.98B and revenue of 50.47B. Therefore, the gross margin over that period was 89.1%.

AVGO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.

ELV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported an operating income of 2.06B and revenue of 50.47B, resulting in an operating margin of 4.1%.

AVGO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.

ELV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Elevance Health, Inc. reported a net income of 1.46B and revenue of 50.47B, resulting in a net margin of 2.9%.

AVGO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.


Frequently Asked Questions


ELV and AVGO have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AVGO has higher volatility (14.97%) compared to ELV (14.30%). In terms of maximum drawdown, ELV dropped -67.19% vs AVGO's -48.30%.

AVGO currently has the higher Sharpe Ratio (0.73 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELV and AVGO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer